SUVRETTA CAPITAL MANAGEMENT, LLC Holdings

SUVRETTA CAPITAL MANAGEMENT, LLC is an investment fund managing more than 2.41B US dollars. The largest holdings include UnitedHealth Group Incorporated, Union Pacific and Las Vegas Sands Corp.. In Q3 2022 the fund bought assets of total value of 572.44M US dollars and sold assets of total value of 805.63M US dollars.

$2.40B

portfolio value

-3.65%

quarter

-70.18%

1 year

-69.23%

3 years

-62.94%

5 years

SUVRETTA CAPITAL MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	1159318000	480350000
Q2 2016	1215320000	847811000
Q3 2016	931303000	680901000
Q4 2016	1667987000	1251727000
Q1 2017	1302701000	1086028000
Q2 2017	1046469000	928465000
Q3 2017	556289000	497011000
Q4 2017	1671666000	1320407000
Q1 2018	1085247000	1481950000
Q2 2018	1066508000	932895000
Q3 2018	1516115000	893786000
Q4 2018	378211000	3052905000
Q1 2019	1700995000	280633000
Q2 2019	2225549000	999408000
Q3 2019	1846519000	1659334000
Q4 2019	2249581000	1608689000
Q1 2020	1514520000	2141417000
Q2 2020	1924565000	1070095000
Q3 2020	1832525000	1004295000
Q4 2020	2166276000	708639000
Q1 2021	2458887000	2754928000
Q2 2021	1884017000	1945873000
Q3 2021	1140449000	1670398000
Q4 2021	1076024000	1791187000
Q1 2022	884453000	2697912000
Q2 2022	532299000	1147705000
Q3 2022	572440000	805627000

SUVRETTA CAPITAL MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 5.05% Portfolio value: 121.71M Avg. open price: $259.17 Current price: $535.04 P/L: +106.44% Sold -47.24% shares Q1 2022	share	5.05%	121.71M	$259.17	$535.04	+106.44%	Sold -47.24% shares Q1 2022
Railroads Union Pacific Corporation Portfolio share: 4.31% Portfolio value: 103.86M Avg. open price: $204.82 Current price: $211.06 P/L: +3.05% Bought +0.20% shares Q3 2022	share	4.31%	103.86M	$204.82	$211.06	+3.05%	Bought +0.20% shares Q3 2022
Resorts & Casinos Las Vegas Sands Corp. Portfolio share: 3.73% Portfolio value: 89.82M Avg. open price: $38.87 Current price: $47.7 P/L: +22.72% Sold -17.56% shares Q3 2022	share	3.73%	89.82M	$38.87	$47.7	+22.72%	Sold -17.56% shares Q3 2022
Software—Infrastructure Microsoft Corporation Portfolio share: 3.70% Portfolio value: 89.05M Avg. open price: $81.81 Current price: $250.2 P/L: +205.83% Bought +52.86% shares Q3 2022	share	3.70%	89.05M	$81.81	$250.2	+205.83%	Bought +52.86% shares Q3 2022
Entertainment The Walt Disney Company Portfolio share: 3.63% Portfolio value: 87.43M Avg. open price: $96.89 Current price: $95.93 P/L: -1.00% Bought +164.12% shares Q3 2022	share	3.63%	87.43M	$96.89	$95.93	-1.00%	Bought +164.12% shares Q3 2022
Internet Retail Amazon.com, Inc. Portfolio share: 3.44% Portfolio value: 82.88M Avg. open price: $1,840.54 Current price: $91.02 P/L: -95.05% N/A Q3 2022	share	3.44%	82.88M	$1,840.54	$91.02	-95.05%	N/A Q3 2022
Specialty Industrial Machinery Otis Worldwide Corporation Portfolio share: 3.44% Portfolio value: 82.77M Avg. open price: $66.37 Current price: $78.48 P/L: +18.25% Sold -47.78% shares Q1 2022	share	3.44%	82.77M	$66.37	$78.48	+18.25%	Sold -47.78% shares Q1 2022
Household & Personal Products The Estée Lauder Companies Inc. Portfolio share: 3.31% Portfolio value: 79.79M Avg. open price: $253.25 Current price: $231.47 P/L: -8.60% Bought +26.15% shares Q3 2022	share	3.31%	79.79M	$253.25	$231.47	-8.60%	Bought +26.15% shares Q3 2022
Biotechnology Royalty Pharma plc Portfolio share: 3.07% Portfolio value: 74.04M Avg. open price: $40.93 Current price: $43.01 P/L: +5.09% Sold -40.14% shares Q3 2022	share	3.07%	74.04M	$40.93	$43.01	+5.09%	Sold -40.14% shares Q3 2022
Specialty Business Services Global Payments Inc. Portfolio share: 2.96% Portfolio value: 71.20M Avg. open price: $128.06 Current price: $101.43 P/L: -20.79% Bought +129.44% shares Q3 2022	share	2.96%	71.20M	$128.06	$101.43	-20.79%	Bought +129.44% shares Q3 2022
Internet Content & Information Meta Platforms, Inc. Portfolio share: 2.81% Portfolio value: 67.60M Avg. open price: N/A Current price: $122.43 P/L: N/A N/A Q3 2022	share	2.81%	67.60M	N/A	$122.43	N/A	N/A Q3 2022
Lodging Hilton Worldwide Holdings Inc. Portfolio share: 2.73% Portfolio value: 65.75M Avg. open price: $93.42 Current price: $139.14 P/L: +48.94% Bought +51.23% shares Q3 2022	share	2.73%	65.75M	$93.42	$139.14	+48.94%	Bought +51.23% shares Q3 2022
Diagnostics & Research IQVIA Holdings Inc. Portfolio share: 2.69% Portfolio value: 64.79M Avg. open price: $162.78 Current price: $211.93 P/L: +30.19% Sold -8.76% shares Q3 2022	share	2.69%	64.79M	$162.78	$211.93	+30.19%	Sold -8.76% shares Q3 2022
Luxury Goods Tapestry, Inc. Portfolio share: 2.57% Portfolio value: 62.00M Avg. open price: $18.53 Current price: $37.15 P/L: +100.49% Sold -2.97% shares Q3 2022	share	2.57%	62.00M	$18.53	$37.15	+100.49%	Sold -2.97% shares Q3 2022
Electronic Gaming & Multimedia Take-Two Interactive Software, Inc. Portfolio share: 2.43% Portfolio value: 58.44M Avg. open price: $118.61 Current price: $106.98 P/L: -9.81% N/A Q3 2022	share	2.43%	58.44M	$118.61	$106.98	-9.81%	N/A Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 2.43% Portfolio value: 58.41M Avg. open price: $299.21 Current price: $267.97 P/L: -10.44% Bought +3.63% shares Q3 2022	share	2.43%	58.41M	$299.21	$267.97	-10.44%	Bought +3.63% shares Q3 2022
Software—Application ServiceNow, Inc. Portfolio share: 2.42% Portfolio value: 58.20M Avg. open price: $475.52 Current price: $392.26 P/L: -17.51% Bought +504.01% shares Q3 2022	share	2.42%	58.20M	$475.52	$392.26	-17.51%	Bought +504.01% shares Q3 2022
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 2.42% Portfolio value: 58.18M Avg. open price: $590.65 Current price: $557.21 P/L: -5.66% Sold -5.48% shares Q3 2022	share	2.42%	58.18M	$590.65	$557.21	-5.66%	Sold -5.48% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 2.30% Portfolio value: 55.50M Avg. open price: $23.04 Current price: $15.82 P/L: -31.34% Bought +1.15% shares Q3 2022	share	2.30%	55.50M	$23.04	$15.82	-31.34%	Bought +1.15% shares Q3 2022
Railroads Canadian Pacific Railway Limited Portfolio share: 2.15% Portfolio value: 51.79M Avg. open price: $63.57 Current price: $80.19 P/L: +26.15% Bought +22.43% shares Q3 2022	share	2.15%	51.79M	$63.57	$80.19	+26.15%	Bought +22.43% shares Q3 2022
Credit Services Mastercard Incorporated Portfolio share: 2.15% Portfolio value: 51.66M Avg. open price: $360.6 Current price: $356.09 P/L: -1.25% Sold -13.11% shares Q3 2022	share	2.15%	51.66M	$360.6	$356.09	-1.25%	Sold -13.11% shares Q3 2022
Telecom Services T-Mobile US, Inc. Portfolio share: 2.06% Portfolio value: 49.62M Avg. open price: $134.54 Current price: $150.62 P/L: +11.95% Bought +371.70% shares Q3 2022	share	2.06%	49.62M	$134.54	$150.62	+11.95%	Bought +371.70% shares Q3 2022
Credit Services Visa Inc. Portfolio share: 2.01% Portfolio value: 48.31M Avg. open price: N/A Current price: $213.68 P/L: N/A Sold -16.27% shares Q3 2022	share	2.01%	48.31M	N/A	$213.68	N/A	Sold -16.27% shares Q3 2022
Medical Distribution AmerisourceBergen Corporation Portfolio share: 1.92% Portfolio value: 46.25M Avg. open price: $118.03 Current price: $171.25 P/L: +45.09% Bought +8.61% shares Q3 2022	share	1.92%	46.25M	$118.03	$171.25	+45.09%	Bought +8.61% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 1.83% Portfolio value: 44.1M Avg. open price: $79.76 Current price: $98.48 P/L: +23.47% Bought +46.42% shares Q3 2022	share	1.83%	44.1M	$79.76	$98.48	+23.47%	Bought +46.42% shares Q3 2022
Biotechnology Arcellx, Inc. Portfolio share: 1.75% Portfolio value: 42.22M Avg. open price: $14.02 Current price: $19.45 P/L: +38.73% Sold -8.95% shares Q3 2022	share	1.75%	42.22M	$14.02	$19.45	+38.73%	Sold -8.95% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 1.65% Portfolio value: 39.64M Avg. open price: $36.68 Current price: $54.25 P/L: +47.90% Sold -36.36% shares Q3 2022	share	1.65%	39.64M	$36.68	$54.25	+47.90%	Sold -36.36% shares Q3 2022
Software—Infrastructure Block, Inc. Portfolio share: 1.51% Portfolio value: 36.37M Avg. open price: $239.84 Current price: $63.14 P/L: -73.67% Sold -2.67% shares Q3 2022	share	1.51%	36.37M	$239.84	$63.14	-73.67%	Sold -2.67% shares Q3 2022
Medical Distribution McKesson Corporation Portfolio share: 1.48% Portfolio value: 35.63M Avg. open price: $306.27 Current price: $382.44 P/L: +24.87% Bought +0.05% shares Q3 2022	share	1.48%	35.63M	$306.27	$382.44	+24.87%	Bought +0.05% shares Q3 2022
Resorts & Casinos Las Vegas Sands Corp. Portfolio share: 1.39% Portfolio value: 33.39M Avg. open price: $38.87 Current price: $47.7 P/L: +22.72% N/A Q3 2022	call	1.39%	33.39M	$38.87	$47.7	+22.72%	N/A Q3 2022
PROKIDNEY CORP Portfolio share: 1.19% Portfolio value: 28.77M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	1.19%	28.77M	N/A	N/A	N/A	N/A Q3 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 1.19% Portfolio value: 28.54M Avg. open price: $19.57 Current price: $6.56 P/L: -66.48% Bought +5.14% shares Q3 2022	share	1.19%	28.54M	$19.57	$6.56	-66.48%	Bought +5.14% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 1.17% Portfolio value: 28.20M Avg. open price: $12.97 Current price: $7.07 P/L: -45.49% Sold -25.76% shares Q3 2022	share	1.17%	28.20M	$12.97	$7.07	-45.49%	Sold -25.76% shares Q3 2022
Biotechnology Sutro Biopharma, Inc. Portfolio share: 1.16% Portfolio value: 27.86M Avg. open price: $13.42 Current price: $7.39 P/L: -44.95% Bought +8.07% shares Q3 2022	share	1.16%	27.86M	$13.42	$7.39	-44.95%	Bought +8.07% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 1.15% Portfolio value: 27.79M Avg. open price: $9.02 Current price: $12.5 P/L: +38.58% Bought +210.43% shares Q3 2022	share	1.15%	27.79M	$9.02	$12.5	+38.58%	Bought +210.43% shares Q3 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 1.13% Portfolio value: 27.32M Avg. open price: $15.33 Current price: $22.77 P/L: +48.52% Sold -22.09% shares Q3 2022	share	1.13%	27.32M	$15.33	$22.77	+48.52%	Sold -22.09% shares Q3 2022
Biotechnology Agios Pharmaceuticals, Inc. Portfolio share: 1.13% Portfolio value: 27.12M Avg. open price: $38.05 Current price: $29.8 P/L: -21.69% Sold -58.69% shares Q3 2022	share	1.13%	27.12M	$38.05	$29.8	-21.69%	Sold -58.69% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 1.10% Portfolio value: 26.51M Avg. open price: $22.61 Current price: $19.89 P/L: -12.04% Sold -40.79% shares Q3 2022	share	1.10%	26.51M	$22.61	$19.89	-12.04%	Sold -40.79% shares Q3 2022
Biotechnology EyePoint Pharmaceuticals, Inc. Portfolio share: 1.06% Portfolio value: 25.57M Avg. open price: $10.32 Current price: $3.33 P/L: -67.75% Bought +8.94% shares Q3 2022	share	1.06%	25.57M	$10.32	$3.33	-67.75%	Bought +8.94% shares Q3 2022
Biotechnology KalVista Pharmaceuticals, Inc. Portfolio share: 1.03% Portfolio value: 24.77M Avg. open price: $19.15 Current price: $5.17 P/L: -73.00% Sold -11.47% shares Q3 2022	share	1.03%	24.77M	$19.15	$5.17	-73.00%	Sold -11.47% shares Q3 2022
Biotechnology Marinus Pharmaceuticals, Inc. Portfolio share: 0.98% Portfolio value: 23.52M Avg. open price: $12.14 Current price: $4.63 P/L: -61.87% Bought +0.77% shares Q3 2022	share	0.98%	23.52M	$12.14	$4.63	-61.87%	Bought +0.77% shares Q3 2022
Biotechnology Prothena Corporation plc Portfolio share: 0.80% Portfolio value: 19.19M Avg. open price: N/A Current price: $60.39 P/L: N/A N/A Q3 2022	share	0.80%	19.19M	N/A	$60.39	N/A	N/A Q3 2022
Waste Management GFL Environmental Inc. Portfolio share: 0.79% Portfolio value: 19.06M Avg. open price: $20.67 Current price: $28.67 P/L: +38.70% Sold -16.53% shares Q3 2022	share	0.79%	19.06M	$20.67	$28.67	+38.70%	Sold -16.53% shares Q3 2022
Lodging Marriott International, Inc. Portfolio share: 0.78% Portfolio value: 18.89M Avg. open price: N/A Current price: $162.04 P/L: N/A Sold -53.94% shares Q3 2022	share	0.78%	18.89M	N/A	$162.04	N/A	Sold -53.94% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.75% Portfolio value: 18.01M Avg. open price: $5.73 Current price: $6.72 P/L: +17.28% Sold -22.67% shares Q3 2022	share	0.75%	18.01M	$5.73	$6.72	+17.28%	Sold -22.67% shares Q3 2022
Biotechnology Heron Therapeutics, Inc. Portfolio share: 0.49% Portfolio value: 11.84M Avg. open price: $11.79 Current price: $2.54 P/L: -78.45% Sold -13.66% shares Q3 2022	share	0.49%	11.84M	$11.79	$2.54	-78.45%	Sold -13.66% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 0.47% Portfolio value: 11.38M Avg. open price: N/A Current price: $369.29 P/L: N/A N/A Q3 2022	share	0.47%	11.38M	N/A	$369.29	N/A	N/A Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.46% Portfolio value: 11.18M Avg. open price: N/A Current price: $50.99 P/L: N/A N/A Q3 2022	share	0.46%	11.18M	N/A	$50.99	N/A	N/A Q3 2022
Biotechnology PepGen Inc. Portfolio share: 0.45% Portfolio value: 10.72M Avg. open price: N/A Current price: $14.98 P/L: N/A Sold -0.04% shares Q3 2022	share	0.45%	10.72M	N/A	$14.98	N/A	Sold -0.04% shares Q3 2022
Health Information Services Akili, Inc. Portfolio share: 0.34% Portfolio value: 8.19M Avg. open price: N/A Current price: $1.75 P/L: N/A N/A Q3 2022	share	0.34%	8.19M	N/A	$1.75	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Alvotech Portfolio share: 0.28% Portfolio value: 6.76M Avg. open price: N/A Current price: $6.56 P/L: N/A N/A Q2 2022	share	0.28%	6.76M	N/A	$6.56	N/A	N/A Q2 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 0.27% Portfolio value: 6.50M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q3 2022	share	0.27%	6.50M	N/A	$28.09	N/A	N/A Q3 2022
Biotechnology Mereo BioPharma Group plc Portfolio share: 0.26% Portfolio value: 6.34M Avg. open price: $3.47 Current price: $0.83 P/L: -76.03% Sold -19.44% shares Q3 2022	share	0.26%	6.34M	$3.47	$0.83	-76.03%	Sold -19.44% shares Q3 2022
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 0.25% Portfolio value: 6.08M Avg. open price: $7.62 Current price: $4.02 P/L: -47.21% Bought +50.71% shares Q3 2022	share	0.25%	6.08M	$7.62	$4.02	-47.21%	Bought +50.71% shares Q3 2022
Biotechnology Pharvaris N.V. Portfolio share: 0.24% Portfolio value: 5.72M Avg. open price: N/A Current price: $2.02 P/L: N/A Sold -9.74% shares Q3 2022	share	0.24%	5.72M	N/A	$2.02	N/A	Sold -9.74% shares Q3 2022
Biotechnology InflaRx N.V. Portfolio share: 0.24% Portfolio value: 5.66M Avg. open price: N/A Current price: $2.5 P/L: N/A Sold -34.67% shares Q3 2022	share	0.24%	5.66M	N/A	$2.5	N/A	Sold -34.67% shares Q3 2022
Biotechnology Solid Biosciences Inc. Portfolio share: 0.17% Portfolio value: 4.19M Avg. open price: $5.35 Current price: $6.46 P/L: +20.69% Sold -88.16% shares Q3 2022	share	0.17%	4.19M	$5.35	$6.46	+20.69%	Sold -88.16% shares Q3 2022
Biotechnology Atai Life Sciences N.V. Portfolio share: 0.17% Portfolio value: 4.05M Avg. open price: $3.64 Current price: $3.48 P/L: -4.40% Bought +0.95% shares Q3 2022	share	0.17%	4.05M	$3.64	$3.48	-4.40%	Bought +0.95% shares Q3 2022
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 0.16% Portfolio value: 3.95M Avg. open price: $15.83 Current price: $1.4 P/L: -91.16% Bought +19.81% shares Q3 2022	share	0.16%	3.95M	$15.83	$1.4	-91.16%	Bought +19.81% shares Q3 2022
Biotechnology Gemini Therapeutics, Inc. Portfolio share: 0.16% Portfolio value: 3.89M Avg. open price: $11.43 Current price: $1.7 P/L: -85.12% Bought +10.97% shares Q4 2021	share	0.16%	3.89M	$11.43	$1.7	-85.12%	Bought +10.97% shares Q4 2021
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 0.16% Portfolio value: 3.79M Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	0.16%	3.79M	N/A	$22	N/A	N/A Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 0.15% Portfolio value: 3.68M Avg. open price: $84.25 Current price: $39.83 P/L: -52.72% Sold -74.48% shares Q3 2022	share	0.15%	3.68M	$84.25	$39.83	-52.72%	Sold -74.48% shares Q3 2022
Biotechnology Molecular Partners AG Portfolio share: 0.11% Portfolio value: 2.67M Avg. open price: N/A Current price: $6.82 P/L: N/A N/A Q2 2021	share	0.11%	2.67M	N/A	$6.82	N/A	N/A Q2 2021
Biotechnology Aeglea BioTherapeutics, Inc. Portfolio share: 0.09% Portfolio value: 2.13M Avg. open price: $6.72 Current price: $0.47 P/L: -92.99% Bought +57.91% shares Q1 2022	share	0.09%	2.13M	$6.72	$0.47	-92.99%	Bought +57.91% shares Q1 2022
Biotechnology Nuvalent, Inc. Portfolio share: 0.08% Portfolio value: 1.96M Avg. open price: N/A Current price: $34.16 P/L: N/A N/A Q3 2022	share	0.08%	1.96M	N/A	$34.16	N/A	N/A Q3 2022
Biotechnology Sio Gene Therapies Inc. Portfolio share: 0.07% Portfolio value: 1.65M Avg. open price: $2.17 Current price: $0.32 P/L: -85.25% Bought +7.74% shares Q4 2021	share	0.07%	1.65M	$2.17	$0.32	-85.25%	Bought +7.74% shares Q4 2021
Biotechnology Ambrx Biopharma Inc. Portfolio share: 0.07% Portfolio value: 1.61M Avg. open price: $9 Current price: $0.52 P/L: -94.23% Bought +41.04% shares Q1 2022	share	0.07%	1.61M	$9	$0.52	-94.23%	Bought +41.04% shares Q1 2022
Biotechnology Otonomy, Inc. Portfolio share: 0.04% Portfolio value: 928K Avg. open price: $4.57 Current price: $0.13 P/L: -97.13% Bought +17.40% shares Q1 2022	share	0.04%	928K	$4.57	$0.13	-97.13%	Bought +17.40% shares Q1 2022
Shell Companies Frazier Lifesciences Acquisition Corporation Portfolio share: 0.04% Portfolio value: 872K Avg. open price: N/A Current price: $9.87 P/L: N/A N/A Q1 2021	share	0.04%	872K	N/A	$9.87	N/A	N/A Q1 2021
Biotechnology Biohaven Ltd. Portfolio share: 0.02% Portfolio value: 388K Avg. open price: N/A Current price: $16.32 P/L: N/A N/A Q3 2022	share	0.02%	388K	N/A	$16.32	N/A	N/A Q3 2022
Biotechnology Benitec Biopharma Inc. Portfolio share: 0.01% Portfolio value: 286K Avg. open price: N/A Current price: $0.17 P/L: N/A N/A Q2 2021	share	0.01%	286K	N/A	$0.17	N/A	N/A Q2 2021
OPY ACQUISITION CORP I Portfolio share: 0.00% Portfolio value: 8K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.00%	8K	N/A	N/A	N/A	N/A Q2 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $60.91 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$60.91	N/A	Sold -100.00% shares Q3 2022
Information Technology Services Fidelity National Information Services, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $142.07 Current price: $72.87 P/L: -48.71% Sold -100.00% shares Q3 2022	share	0.00%	0	$142.07	$72.87	-48.71%	Sold -100.00% shares Q3 2022
Oil & Gas Integrated Exxon Mobil Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $106.85 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$106.85	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Viatris Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.92 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.92	N/A	Sold -100.00% shares Q3 2022
Biotechnology Entrada Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $17.96 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$17.96	N/A	Sold -100.00% shares Q3 2022
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.04 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.04	N/A	Sold -100.00% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $16.32 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$16.32	N/A	Sold -100.00% shares Q3 2022
Shell Companies Eucrates Biomedical Acquisition Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.92 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$9.92	N/A	Sold -100.00% shares Q3 2022
Shell Companies European Biotech Acquisition Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.01 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.01	N/A	Sold -100.00% shares Q3 2022
Biotechnology Crinetics Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $18.32 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$18.32	N/A	Sold -100.00% shares Q3 2022
Shell Companies Omega Alpha SPAC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.06 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.06	N/A	Sold -100.00% shares Q3 2022
Oil & Gas E&P ConocoPhillips Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $119.37 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$119.37	N/A	Sold -100.00% shares Q3 2022
Biotechnology Roivant Sciences Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.18 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.18	N/A	Sold -100.00% shares Q3 2022
Biotechnology Chimerix, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $5.72 Current price: $2.22 P/L: -61.21% Sold -100.00% shares Q3 2022	share	0.00%	0	$5.72	$2.22	-61.21%	Sold -100.00% shares Q3 2022
Oil & Gas Integrated Chevron Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $176.56 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$176.56	N/A	Sold -100.00% shares Q3 2022
Oil & Gas E&P Occidental Petroleum Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $66.36 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$66.36	N/A	Sold -100.00% shares Q3 2022
TURMERIC ACQUISITION CORP Portfolio share: 0.00% Portfolio value: 1K Avg. open price: N/A Current price: N/A P/L: N/A Sold -20.84% shares Q2 2022	share	0.00%	1K	N/A	N/A	N/A	Sold -20.84% shares Q2 2022
Healthcare Plans Centene Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $62.87 Current price: $86.35 P/L: +37.35% Sold -100.00% shares Q3 2022	share	0.00%	0	$62.87	$86.35	+37.35%	Sold -100.00% shares Q3 2022
CANO HEALTH INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Shell Companies Turmeric Acquisition Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.03 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.03	N/A	Sold -100.00% shares Q3 2022
Shell Companies OPY Acquisition Corp. I Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.05 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.05	N/A	Sold -100.00% shares Q3 2022
Specialty Retail RH Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $679 Current price: $260.81 P/L: -61.59% Sold -100.00% shares Q3 2022	share	0.00%	0	$679	$260.81	-61.59%	Sold -100.00% shares Q3 2022
Shell Companies Research Alliance Corp. II Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.11 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.11	N/A	Sold -100.00% shares Q3 2022
Beverages—Non-Alcoholic Monster Beverage Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $102.17 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$102.17	N/A	Sold -100.00% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $120.18 Current price: $92.75 P/L: -22.83% Sold -100.00% shares Q3 2022	share	0.00%	0	$120.18	$92.75	-22.83%	Sold -100.00% shares Q3 2022
Internet Content & Information Match Group, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $45.78 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$45.78	N/A	Sold -100.00% shares Q3 2022
Software—Infrastructure Marqeta, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.39 Current price: $6.44 P/L: -62.97% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.39	$6.44	-62.97%	Sold -100.00% shares Q3 2022
Biotechnology Immuneering Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.11 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.11	N/A	Sold -100.00% shares Q3 2022
Biotechnology Terns Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $10.43 Current price: $6.09 P/L: -41.61% Sold -100.00% shares Q3 2022	share	0.00%	0	$10.43	$6.09	-41.61%	Sold -100.00% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $422.65 Current price: $547.42 P/L: +29.52% Sold -100.00% shares Q3 2022	share	0.00%	0	$422.65	$547.42	+29.52%	Sold -100.00% shares Q3 2022

Showing TOP 102 SUVRETTA CAPITAL MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of SUVRETTA CAPITAL MANAGEMENT, LLC?

The biggest position of the SUVRETTA CAPITAL MANAGEMENT, LLC is UnitedHealth Group Incorporated (UNH) with 5.05% portfolio share worth of 121.71M US dollars.

Top 5 SUVRETTA CAPITAL MANAGEMENT's holdings represent 20.43% of the portfolio:

UnitedHealth Group Incorporated (UNH) – 5.05%
Union Pacific Corporation (UNP) – 4.31%
Las Vegas Sands Corp. (LVS) – 3.73%
Microsoft Corporation (MSFT) – 3.7%
The Walt Disney Company (DIS) – 3.63%

Who is the portfolio manager of SUVRETTA CAPITAL MANAGEMENT, LLC?

The portfolio manager of the SUVRETTA CAPITAL MANAGEMENT, LLC is .

What is the total asset value of the SUVRETTA CAPITAL MANAGEMENT, LLC portfolio?

SUVRETTA CAPITAL MANAGEMENT, LLC total asset value (portfolio value) is 2.41B US dollars.

Who is ?

is the portfolio manager of the SUVRETTA CAPITAL MANAGEMENT, LLC.

What is (SUVRETTA CAPITAL MANAGEMENT, LLC) fund performance?

SUVRETTA CAPITAL MANAGEMENT's quarterly performance is -3.65%, annualy -70.18%. In the past 3 years, the value of 's portfolio has decreased by -69%. In the past 5 years, the value of the portfolio has decreased by -63%.

What is the SUVRETTA CAPITAL MANAGEMENT, LLC CIK?

SUVRETTA CAPITAL MANAGEMENT's Central Index Key is 0001569064 .

SUVRETTA CAPITAL MANAGEMENT, LLC Holdings

SUVRETTA CAPITAL MANAGEMENT, LLC portfolio value:

SUVRETTA CAPITAL MANAGEMENT, LLC quarter portfolio value change:

SUVRETTA CAPITAL MANAGEMENT, LLC 1 year portfolio value change:

SUVRETTA CAPITAL MANAGEMENT, LLC 3 years portfolio value change:

SUVRETTA CAPITAL MANAGEMENT, LLC 5 years portfolio value change: